Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes

BACKGROUND: The positive relationship between metabolic healthy obesity (MHO) and cardiovascular risk has been under debate in recent years. Previously, strong evidence supported the causal role of increased plasma lipoprotein(a) [Lp(a)] levels in cardiovascular disease (CVD). The current study aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Jing-Lu, Zhang, Hui-Wen, Liu, Hui-Hui, Zhu, Cheng-Gang, Guo, Yuan-Lin, Wu, Na-Qiong, Xu, Rui-Xia, Dong, Qian, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163309/
https://www.ncbi.nlm.nih.gov/pubmed/35669468
http://dx.doi.org/10.3389/fcvm.2022.870341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163309/
https://www.ncbi.nlm.nih.gov/pubmed/35669468
http://dx.doi.org/10.3389/fcvm.2022.870341

Ejemplares similares